Cwm, LLC Crispr Therapeutics Ag Transaction History

Cwm, LLC

$23.3 Billion
Q3 2024

A detailed history of Cwm, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Cwm, LLC holds 19,254 shares of CRSP stock, worth $921,881. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,254

Previous 22,386 13.99%

Holding current value

$921,881

Previous $1.21 Million 25.14%

% of portfolio

0.0%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	SELL	$44.62 - $62.75 $139,749 - $196,533	-3,132 Reduced 13.99%	19,254 $905,000
Q2 2024 Jul 09, 2024	BUY	$51.17 - $68.18 $1.14 Million - $1.51 Million	22,199 Added 11871.12%	22,386 $1.21 Million
Q1 2024 Apr 05, 2024	BUY	$60.67 - $89.12 $788 - $1,158	13 Added 7.47%	187 $13,000
Q4 2023 Feb 01, 2024	SELL	$38.62 - $72.18 $15,756 - $29,449	-408 Reduced 70.1%	174 $11,000
Q3 2023 Oct 11, 2023	BUY	$45.39 - $59.0 $11,801 - $15,340	260 Added 80.75%	582 $26,000
Q2 2023 Aug 03, 2023	BUY	$43.47 - $67.77 $4,694 - $7,319	108 Added 50.47%	322 $18,000
Q1 2023 Apr 28, 2023	SELL	$41.0 - $56.12 $4,182 - $5,724	-102 Reduced 32.28%	214 $10,000
Q4 2022 Feb 01, 2023	SELL	$39.19 - $65.67 $3,487 - $5,844	-89 Reduced 21.98%	316 $13,000
Q3 2022 Oct 27, 2022	SELL	$61.1 - $83.78 $13,808 - $18,934	-226 Reduced 35.82%	405 $26,000
Q2 2022 Jul 28, 2022	SELL	$43.23 - $73.83 $1.17 Million - $1.99 Million	-26,949 Reduced 97.71%	631 $38,000
Q1 2022 Apr 21, 2022	SELL	$53.19 - $79.24 $222,546 - $331,540	-4,184 Reduced 13.17%	27,580 $1.73 Million
Q4 2021 Jan 31, 2022	BUY	$70.09 - $111.29 $2.22 Million - $3.53 Million	31,714 Added 63428.0%	31,764 $2.41 Million
Q1 2021 Sep 15, 2021	SELL	$110.72 - $210.04 $10,075 - $19,113	-91 Reduced 64.54%	50 $8,000
Q1 2021 Apr 27, 2021	BUY	$110.72 - $210.04 $10,075 - $19,113	91 Added 182.0%	141 $17,000
Q4 2020 Sep 15, 2021	BUY	$79.67 - $173.23 $3,983 - $8,661	50 New	50 $8,000
Q4 2020 Jan 27, 2021	SELL	$79.67 - $173.23 $3,983 - $8,661	-50 Closed	0 $0
Q3 2020 Sep 15, 2021	BUY	$78.5 - $100.64 $3,925 - $5,032	50 New	50 $8,000
Q3 2020 Oct 19, 2020	SELL	$78.5 - $100.64 $3,925 - $5,032	-50 Closed	0 $0
Q2 2020 Sep 15, 2021	BUY	$38.5 - $76.05 $1,925 - $3,802	50 New	50 $8,000
Q2 2020 Jul 22, 2020	SELL	$38.5 - $76.05 $1,925 - $3,802	-50 Closed	0 $0
Q1 2020 Sep 15, 2021	BUY	$33.68 - $62.53 $1,684 - $3,126	50 New	50 $8,000
Q1 2020 Apr 28, 2020	SELL	$33.68 - $62.53 $1,684 - $3,126	-50 Closed	0 $0
Q4 2019 Sep 14, 2021	BUY	$36.68 - $73.13 $1,834 - $3,656	50 New	50 $8,000
Q4 2019 Jan 27, 2020	SELL	$36.68 - $73.13 $1,834 - $3,656	-50 Closed	0 $0
Q3 2019 Sep 14, 2021	SELL	$40.99 - $52.56 $2,869 - $3,679	-70 Reduced 58.33%	50 $8,000
Q3 2019 Oct 22, 2019	BUY	$40.99 - $52.56 $2,869 - $3,679	70 Added 140.0%	120 $5,000
Q2 2019 Sep 14, 2021	BUY	$35.45 - $48.2 $1,772 - $2,410	50 New	50 $8,000
Q2 2019 Jul 31, 2019	SELL	$35.45 - $48.2 $1,772 - $2,410	-50 Closed	0 $0
Q1 2019 Sep 02, 2021	BUY	$28.02 - $40.87 $1,401 - $2,043	50 New	50 $0

Others Institutions Holding CRSP

# of Institutions

491

Shares Held

58M

Call Options Held

1.1M

Put Options Held

1.9M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.74B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account